Axonics Inc (NAS:AXNX)
$ 67.13 0 (0%) Market Cap: 3.42 Bil Enterprise Value: 3.12 Bil PE Ratio: 0 PB Ratio: 5.46 GF Score: 83/100

Axonics Inc at Wells Fargo Healthcare Conference Transcript

Sep 08, 2022 / 02:25PM GMT
Release Date Price: $75.48 (+5.02%)
Larry Biegelsen
Wells Fargo - Analyst

All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It is my pleasure to host this session with Axonics. With us, we have Ray Cohen, the CEO; and Dan Dearen, the President and CFO.

In terms of format, it's going to be a fireside chat. If anybody has a question, raise your hand and we will call on you. So Ray and Dan, thanks so much for being here.

Ray Cohen
Axonics, Inc. - CEO

Thank you. Appreciate the invite.

Questions & Answers

Larry Biegelsen
Wells Fargo - Analyst

So Ray, let's start with the macro environment. On the Q2 call, you indicated that COVID deferrals and procedures slowed down and slowdowns and staffing shortages did not really impact your Q2 results. But you did note some supply chain challenges and higher costs for certain components, which you've been able to manage the impact of so far. So how do you see the macro environment right now? What's getting better, what's getting worse?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot